OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

ASTRAZENECA PLC DL-25/  GB0009895292  /

Quotrix
04/11/2024  20:37:17 Chg. +2.8500 Volume Bid22:00:01 Ask22:00:01 Market Capitalization Dividend Y. P/E Ratio
131.9000EUR +2.21% 9
Turnover: 1,187.1000		 130.6500Bid Size: 60 132.3500Ask Size: 60 205.21 bill.EUR - -
Newsfile Corp 15:00 Elsevier Supports Pistoia Alliance in Accelerating Safe and Responsible AI Adoption in Drug Discover...
GlobeNewswire 12/08 Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune...
GlobeNewswire 08/08 Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets...
GlobeNewswire 06/08 Cellectis Provides Financial Results for the Second Quarter 2024
TeleTrader 25/07 AstraZeneca's Q2 revenue up by 13% to $12.94B
GlobeNewswire 15/07 AstraZeneca Closes Acquisition of Amolyt Pharma
GlobeNewswire 26/06 As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire 20/06 Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire 18/06 Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire 18/06 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 13/06 Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire 28/05 Cellectis Reports Financial Results for First Quarter 2024
TeleTrader 21/05 AstraZeneca to deliver $80B total revenue by 2030
TeleTrader 20/05 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 08/05 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 08/05 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire 06/05 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 06/05 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 29/04 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 25/04 Europe opens mostly down after corporate earnings
TeleTrader 25/04 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 01/04 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire 28/03 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire 19/03 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
TeleTrader 19/03 AstraZeneca to acquire Fusion for $2 billion